Evidence map›Paper›PMID 36267161›Full record

ArticleDermatology reports2022

Skin reaction to COVID-19 vaccine: A report of 4 cases.

Mariabeatrice Bertolani, Maria Beatrice de Felici Del Giudice, Erminia Ridolo, Francesco Pucciarini, Claudio Feliciani, Francesca Satolli

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Dermatology reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Mariabeatrice BertolaniSection of Dermatology, Department of Medicine and Surgery.
Maria Beatrice de Felici Del GiudiceSection of Dermatology, Department of Medicine and Surgery.
Erminia RidoloMedicine and Surgery Department, Allergy and Clinical Immunology, University of Parma, Italy.
Francesco PucciariniMedicine and Surgery Department, Allergy and Clinical Immunology, University of Parma, Italy.
Claudio FelicianiSection of Dermatology, Department of Medicine and Surgery.
Francesca SatolliSection of Dermatology, Department of Medicine and Surgery.
University of Parma · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the beginning of the covid-vaccine campaign, a lot of local and systemic dermatologic reactions happening after the administration of Coronavirus disease 2019 (COVID-19) vaccines have been described, even if their exact biological mechanism is still debated. In this paper we report 4 cases of cutaneous manifestations arose within ten days after the first dose of messenger RNA (mRNA)-based COVID-19 vaccination: one case of giant urticaria, one case of head and neck redness and two cases of Erythema Multiforme (EM). In our experience these reactions were mild, transient and all of them resolved, not recurring after the second dose, so these manifestations shouldn't be considered as an absolute contraindication to the second dose of vaccine, that to date is fundamental.

Indexed as

COVID-19Skin reactionVaccination

Identifiers

PMID36267161
PMCPMC9577375
OpenAlexW4285092849

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.